AI assistant
Sending…
IONIS PHARMACEUTICALS INC — Director's Dealing 2015
Feb 13, 2015
30591_dirs_2015-02-13_23d404a2-9eb5-4969-a1b5-34020daa719c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ISIS PHARMACEUTICALS INC (ISIS)
CIK: 0000874015
Period of Report: 2015-02-11
Reporting Person: KLEIN JOSEPH III (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-02-11 | Common Stock | G | 2000 | — | Disposed | 1095 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 100 | Indirect |
Footnotes
F1: Pursuant to a charitable gift
More from IONIS PHARMACEUTICALS INC
Regulatory Filings
2026
May 28
Major Shareholding Notification
2026
Apr 30
Interim / Quarterly Report
2026
Apr 29
Earnings Release
2026
Apr 29
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Regulatory Filings
2026
Apr 21
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 24